Metabolic bone disease (MBD) of prematurity remains a significant problem for preterm, chronically ill neonates. The definition and recommendations for screening and treatment of MBD vary in the literature. A recent American Academy of Pediatrics Consensus Statement may help close the gap in institutional variation, but evidence based practice guidelines remain obscure due to lack of normative data and clinical trials for preterm infants. This review highlights mineral homeostasis physiology, current recommendations in screening and monitoring, prevention and treatment strategies, and an added perspective of a bone health team serving a high volume referral neonatal intensive care center.
Metabolic bone disease of prematurity
Stacy E. Rustico,Andrew C. Calabria,Samuel J. Garber
Published 2014 in Journal of Clinical & Translational Endocrinology
ABSTRACT
PUBLICATION RECORD
- Publication year
2014
- Venue
Journal of Clinical & Translational Endocrinology
- Publication date
2014-07-04
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-45 of 45 references · Page 1 of 1